半夏后蒲汤治疗惊恐障碍的有效性和安全性:一项初步研究

Traditional & Kampo Medicine Pub Date : 2022-08-31 DOI:10.1002/tkm2.1348

K. C. Nakajima‐Ohyama, Y. Shizusawa, H. Tanimukai

{"title":"半夏后蒲汤治疗惊恐障碍的有效性和安全性:一项初步研究","authors":"K. C. Nakajima‐Ohyama, Y. Shizusawa, H. Tanimukai","doi":"10.1002/tkm2.1348","DOIUrl":null,"url":null,"abstract":"The prevalence of panic disorder in patients with comorbidities is higher than in the general population. Selective serotonin reuptake inhibitors (SSRIs) or benzodiazepines, the common pharmacotherapy, can cause adverse effects in the patients. To research other options, we report a retrospective pilot study on hangekobokuto in treating panic disorder.","PeriodicalId":23213,"journal":{"name":"Traditional & Kampo Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Efficacy and safety of hangekobokuto (Banxia‐houpo‐tang) in treating panic disorder: A pilot study\",\"authors\":\"K. C. Nakajima‐Ohyama, Y. Shizusawa, H. Tanimukai\",\"doi\":\"10.1002/tkm2.1348\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The prevalence of panic disorder in patients with comorbidities is higher than in the general population. Selective serotonin reuptake inhibitors (SSRIs) or benzodiazepines, the common pharmacotherapy, can cause adverse effects in the patients. To research other options, we report a retrospective pilot study on hangekobokuto in treating panic disorder.\",\"PeriodicalId\":23213,\"journal\":{\"name\":\"Traditional & Kampo Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-08-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Traditional & Kampo Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/tkm2.1348\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Traditional & Kampo Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/tkm2.1348","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

摘要

惊恐障碍在合并症患者中的患病率高于一般人群。选择性血清素再摄取抑制剂(SSRIs)或苯二氮卓类药物是常用的药物治疗方法，可引起患者的不良反应。为了研究其他选择，我们报告了一项回顾性的试点研究，用hangekobokuto治疗恐慌症。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Efficacy and safety of hangekobokuto (Banxia‐houpo‐tang) in treating panic disorder: A pilot study

The prevalence of panic disorder in patients with comorbidities is higher than in the general population. Selective serotonin reuptake inhibitors (SSRIs) or benzodiazepines, the common pharmacotherapy, can cause adverse effects in the patients. To research other options, we report a retrospective pilot study on hangekobokuto in treating panic disorder.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Traditional & Kampo Medicine

自引率

0.00%

发文量